Shares of Star Scientific, Inc. (Nasdaq: CIGX) plunged almost 50% today on the decision issued today by the Federal Circuit Court of Appeals. Star Scientific, Inc. so far lost its patent-infringement trial against Reynolds American Inc.
A few quick facts: Star Scientific has numerous valid patents, their CigRX is a proven working product, Anatabloc launch is expected soon.
To make long CIGX‘s story short: market overreacting & bounce is expecting (read today’s press release here)
Star Scientific, Inc.
4470 Cox Road
Glen Allen, VA 23060
United States – Map
Star Scientific, Inc.’s corporate mission is centered on reducing toxins in tobacco so that adult consumers can have access to products that expose them to sharply reduced toxin levels. The company was founded on the belief that is technologically possible to lessen the health risks associated with long-term tobacco use, and particularly smoking.